Back to search
FDAFDA · Food and drugs·Recall number Z-1258-2022

t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology

Published June 22, 2022 · Recall initiated: September 10, 2020

Summary

FDA records medical device Class II recall Z-1258-2022, published June 22, 2022 and initiated September 10, 2020. Recalling firm: Tandem Diabetes Care Inc; Status: Ongoing; Reported quantity: 5,206; Lot: Dexcom G5 - All Serial Numbers; Basal-IQ Technology - Software Versions 6.3.01 and Earlier. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tandem Diabetes Care Inc
Distributor
International distribution in the country of Australia.
Lot
Dexcom G5 - All Serial Numbers; Basal-IQ Technology - Software Versions 6.3.01 and Earlier
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology recalled?

Yes. FDA published recall Z-1258-2022 on June 22, 2022. Reported hazard: Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

What should I do if I have this product?

Voluntary: Firm initiated · Letter